Arthur Mageau Profile
Arthur Mageau

@ArthurMageau

Followers
93
Following
174
Media
3
Statuses
47

MD., Ph.D. Clinical Chief. Internal medicine unit Bichat Hospital, Paris

Paris, France
Joined May 2012
Don't wanna be here? Send us removal request.
@ArthurMageau
Arthur Mageau
1 year
Congratulations 👏 to #Akachaner for her great talk about immunosuppressive drugs and/or IgIV for the treatment of #susac syndrome at #ACR24 .
1
2
13
@ArthurMageau
Arthur Mageau
1 year
EULAR/PReS recommendations for the diagnosis and management of Still’s disease, comprising systemic juvenile idiopathic arthritis and adult-onset Still’s disease
ard.bmj.com
Systemic juvenile idiopathic arthritis (sJIA) and adult-onset Still’s disease (AOSD) are considered the same disease, but a common approach for diagnosis and management is still missing. Methods In...
0
0
2
@ArthurMageau
Arthur Mageau
1 year
Immunosuppressive agents or intravenous immunoglobulin in addition to glucocorticoids in the treatment of Susac syndrome: a French national cohort study - The Lancet Rheumatology
2
14
32
@ArthurMageau
Arthur Mageau
1 year
Thank you @elizabetharkema for giving me the opportunity to study anti-SARS-CoV2 vaccination 💉coverage and effectivennes in patients living with #SLE #Lupus in Sweden ! https://t.co/JLtNw7lcfL
Tweet card summary image
journals.sagepub.com
Objectives To describe the uptake of anti-SARS-CoV2 vaccination in 2021 and investigate vaccine effectiveness in systemic lupus erythematosus (SLE) patients in ...
0
2
11
@ArthurMageau
Arthur Mageau
1 year
Thanks 🙏🙏 to @RespirologyAPSR for this interesting editorial about our work @RaphaelBorie : Systemic lupus erythematosus: Adding another piece to the connective tissue disease‐associated interstitial lung disease puzzle - Khor - 2024 - Respirology:
Tweet card summary image
onlinelibrary.wiley.com
See related article
0
0
1
@hopitalbichat
Hôpital Bichat - Claude-Bernard AP-HP
1 year
Des investigateurs du centre des maladies rares auto-immunes et auto-inflammatoires systémiques @hopitalbichat @APHP ont mené une étude épidémiologique montrant une incidence élevée de maladies auto-immunes systémiques chez les survivants de sepsis Lire 👉 https://t.co/hJjk5xdkuX
0
1
11
@ArthurMageau
Arthur Mageau
1 year
Congratulations 👏👏 to Clothilde Gros for this important work 📰describing how much the frequency of aPL autoantibodies is high in patients with late pregnancy morbidity : #APS https://t.co/Y5w24z2B48
0
0
2
@gomezg_alvaro
Alvaro Gomez
1 year
Journal Impact Factor (JCR 2024, Web of Science) of top journals in #Rheumatology. Are we already seeing the expected after-COVID drop in JIF ? 🤔 Gentle reminder: JIF shall not be used to assess the quality of individual publications💡 #RheumTwitter
0
8
37
@Clemence_Dvd
Clémence David-Gabarre
1 year
So happy to share my phD work @crow_lab @InstitutImagine published in @JExpMed. We showed that UNC93B1 mutations cause lupus and chilblain lupus via distinct TLR7 and TLR8 activation. A great collaborative effort with @casanova_lab and Manoury team.
@JExpMed
Journal of Experimental Medicine
1 year
David et al. @crow_lab @mrc_hgu @InstitutImagine describe UNC93B1 missense substitutions causing systemic #lupus erythematosus or chilblain lupus, inherited as either autosomal dominant or autosomal recessive traits. https://t.co/zSX65aZYFu #HumanDiseaseGenetics #Autoimmunity
3
16
59
@hopitalbichat
Hôpital Bichat - Claude-Bernard AP-HP
1 year
🔬Félicitations à la Dr Tiphaine Goulenok, service de médecine interne, lauréate pour son projet de recherche sur les maladies à papillomavirus (HPV) chez les patients atteints de maladies systémiques auto-immunes et inflammatoires Découvrez ses travaux 👉 https://t.co/lXDmE1VQbW
0
4
23
@ArthurMageau
Arthur Mageau
2 years
Congratulations 👏to John Tchen 🧑‍🔬, Nicolas Charles and @criu1149 for this original paper published in @NatureComms showing how PD-L1- and IL-4-expressing basophils promote pathogenic accumulation of T follicular helper cells in #SLE : https://t.co/4L0PKnBRvV
0
0
2
@RaphaelBorie
Raphael Borie
2 years
High risk of lung cancer in surfactant-related gene variant carriers https://t.co/zRwbb8AwmD Very proud of this @OrphaLung collaborative work showing the risk of lung cancer in SFTPA1/SFTPA2 mutation carriers particularly if smoking
Tweet card summary image
pubmed.ncbi.nlm.nih.gov
The high risk of lung cancer among SRG variant carriers suggests specific screening and diagnostic and therapeutic challenges. The benefit of regular computed tomography scan follow-up should be...
4
13
27
@ArthurMageau
Arthur Mageau
2 years
Just released 🗞️😀 in @ERSpublications : High risk of lung cancer in surfactant-related gene variant carriers https://t.co/ZOqlL06hQG Congratulations to @RaphaelBorie et @AlexandreBrudon
1
2
10
@ArthurMageau
Arthur Mageau
2 years
Systemic lupus erythematosus: Adding another piece to the connective tissue disease‐associated interstitial lung disease puzzle - Khor - Respirology - Wiley Online Library
Tweet card summary image
onlinelibrary.wiley.com
See related article
0
3
8
@GregoireMDF
Grégoire Martin de Frémont
2 years
La @RevMedInterne inaugure sa rubrique « Les Portraits de la Revue »! L’objectif? Mettre en valeur la pluralité des pratiques et des profils d’internistes en se questionnant sur l’évolution de la spécialité! Retrouvez ce mois ci T.Goulenok, PH à Bichat:
0
5
13
@RheumNow
Dr. John Cush
2 years
1st trimester exposure to Plaquenil is not assoc. w/ risk of congential malformations (MCM). Swedish registry data on 1007 births (453 exposed) & 2500 births (144 exposed) in SLE & RA, respectively. MCM risks in SLE &RA were 3.4-5.7%, no diff betw groups https://t.co/lzbd7AQqy1
0
10
25
@hopitalbichat
Hôpital Bichat - Claude-Bernard AP-HP
2 years
Jeudi 29/02: Journée internationale des maladies rares ! Participez au webinaire organisé par la Plateforme d'expertise maladies rares Paris Nord et découvrez le Dr Tiphaine Goulenok évoquer le partenariat patient dans le syndrome de Suzac https://t.co/zQO2lolIKH #JIMR2024 👏
0
5
11